Hepatotrophic effect of cyclosporine and FK 506 is not mimicked by Rapamycin

By Chavez R.   Jamieson N.   Takamori S.   Nivatvongs S.   Pino G.   Metcalfe A.   Watson C.   Romero D.   Metcalfe S.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2429-2429

Elsevier

Access to resources Recommend Favorite

Rapamycin antagonizes cyclosporin A‐ and tacrolimus (FK506)‐mediated augmentation of linker for activation of T cell expression in T cells

By Cho Clifford S.   Chang Zhen   Elkahwaji Johny   Scheunemann Tara L.   Manthei Eric R.   Colburn Matthew   Knechtle Stuart J.   Hamawy Majed M.  

International Immunology, Vol. 15, Iss. 11, 2003-11 ,pp. : 1369-1378

Oxford University Press

Access to resources Recommend Favorite

FK 506 and Rapamycin in Combination Are Not Antagonistic but Produce Extended Small Bowel Graft Survival in the Mouse

By Chen H.   Qi S.   Xu D.   Vu D.M.   Fitzsimmons W.E.   Bekersky I.   Peets J.   Sehgal S.N.   Daloze P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1039-1041

Elsevier

Access to resources Recommend Favorite

Effect of donor-specific transfusion in combination with FK 506 in rat cardiac allotransplantation

By Antoniou E.A.   Drayson M.   Howie A.J.   McMaster P.   D'Silva M.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 2796-2798

Elsevier

Access to resources Recommend Favorite

Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors

By Yamamoto-Yamaguchi Y.   Okabe-Kado J.   Kasukabe T.   Honma Y.  

Experimental Hematology, Vol. 29, Iss. 5, 2001-05 ,pp. : 582-588

Elsevier

Access to resources Recommend Favorite